HIV CLINICAL TRIALS MARKET Challenges and Opportunities

Conducting clinical trials for HIV therapies and vaccines is an extremely costly process. Various phases of clinical trials require recruiting thousands of human participants and carrying out complex research studies over long periods of time. Moreover, standard therapies and diagnostics need to undergo rigorous testing to prove their safety and efficacy as per regulatory guidelines. This involves setting up proper clinical infrastructure at trial sites, hiring and training clinical research personnel, developing investigational drugs and products, monitoring trials and collecting and analyzing vast amounts of clinical data.

Market Opportunity- Growing demand for innovative therapies and vaccines

There has been growing global demand for more effective, safer and affordable innovative therapies and vaccines for the treatment and prevention of HIV/AIDS. While current antiretroviral treatments have increased lifespan of HIV patients, these regimens still face issues of drug resistance, toxicities, requirement of lifelong adherence and socioeconomic inaccessibility in developing countries. No vaccine has been proven to completely prevent HIV infection even after decades of research.